These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21821671)

  • 1. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.
    Takakura A; Nelson EA; Haque N; Humphreys BD; Zandi-Nejad K; Frank DA; Zhou J
    Hum Mol Genet; 2011 Nov; 20(21):4143-54. PubMed ID: 21821671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystin-1 regulates STAT activity by a dual mechanism.
    Talbot JJ; Shillingford JM; Vasanth S; Doerr N; Mukherjee S; Kinter MT; Watnick T; Weimbs T
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7985-90. PubMed ID: 21518865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.
    Talbot JJ; Song X; Wang X; Rinschen MM; Doerr N; LaRiviere WB; Schermer B; Pei YP; Torres VE; Weimbs T
    J Am Soc Nephrol; 2014 Aug; 25(8):1737-48. PubMed ID: 24578126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
    Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
    J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
    Seo S; Kim H; Hwang JT; Kim JE; Kim J; Jeon S; Song YJ; Choi KH; Sim G; Cho M; Yoon JW; Kim H
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.
    Yanda MK; Liu Q; Cebotaru L
    J Biol Chem; 2018 Jul; 293(29):11513-11526. PubMed ID: 29875161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
    Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R
    FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
    Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
    Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Viau A; Baaziz M; Aka A; Mazloum M; Nguyen C; Kuehn EW; Terzi F; Bienaimé F
    J Am Soc Nephrol; 2020 May; 31(5):1035-1049. PubMed ID: 32238474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
    de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
    Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.
    Stayner C; Shields J; Slobbe L; Shillingford JM; Weimbs T; Eccles MR
    Nephrology (Carlton); 2012 Nov; 17(8):739-47. PubMed ID: 22725947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease.
    Ren Y; Zhu X; Fu K; Zhang H; Zhao W; Lin Y; Fang Q; Wang J; Chen Y; Guo D
    Biochem Pharmacol; 2023 Jan; 207():115355. PubMed ID: 36442624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 18. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
    Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
    Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
    Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
    Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease.
    Sun Y; Liu Z; Cao X; Lu Y; Mi Z; He C; Liu J; Zheng Z; Li MJ; Li T; Xu D; Wu M; Cao Y; Li Y; Yang B; Mei C; Zhang L; Chen Y
    Sci Adv; 2019 Jun; 5(6):eaaw3593. PubMed ID: 31183407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.